India's pharmaceutical exports are estimated to be over Rs 10,000 crore in the financial year 2001-02 against Rs 8,729 crore in fiscal 2000-01.
The growth forecast in exports by the BS Research Bureau is on the basis of a 45.39 per cent rise in exports recorded by 45 listed pharmaceutical companies in 2001-02.
In fiscal 2000-01, the industry had reported around a 31 per cent jump in exports at Rs 8,729 crore from Rs 6,631 crore in 1999-00.
More From This Section
Assuming the industry had maintained a growth rate of around 30 per cent during 2001-02, the estimated exports are likely to be around Rs 11, 300 crore.
Overall, pharmaceutical exports, especially bulk drugs, grew at a compounded annual growth rate of over 27 per cent in the last nine financial years.
Of late, the growth has slowed down. Growth in pharmaceutical exports slipped to 11.27 per cent in fiscal 1999-2000, marginally down from 11.32 percent in 1998-99.
Data from annual reports of listed pharmaceutical companies show that 45 companies registered a 45.39 per cent rise in exports from Rs 3,269 crore in 2000-01 to Rs 4,753 crore in 2001-02.
With exports registering a jump, the exports share in the aggregate sales of this companies increased from 22.7 per cent in 2000-01 to 27.3 per cent in 2001-02.
The domestic pharmaceutical firms put up a good show with exports moving up by 48.32 per cent from Rs 3,115 crore in 2000-01 to Rs 4,620 crore in 2001-02.
The share of the international business of the domestic companies rose from 29 per cent to 33.9 per cent.
The multinational pharmaceutical companies registered a 2.17 per cent decline in exports to Rs 189 crore from Rs 193 crore.
Exports form a vital component of the growth of most Indian pharmaceutical companies.
Ranbaxy Laboratories remained at the number one position with exports of Rs 1,085.51 crore in 2001-02, a rise of 37.18 per cent over the previous year's exports of Rs 791.29 crore.
Dr Reddy's Laboratories, the second largest, showed a 126 per cent growth in exports from Rs 430.94 crore to Rs 975.63 crore.
Cipal has been the third largest with exports of Rs 496.75 crore, a growth of 86.59 per cent. Aurobindo Pharmaceuticals, the fourth largest, recorded a drop in exports in 2001-02 to Rs 495.18 crore from Rs 545.18 crore in 2000-01.
On a region-wise basis, India's biggest export markets are east Asia, followed by west Europe, Africa, North America, and east Europe.
On a country-wise basis, India's five largest export markets are the US, Russia, Germany, Hong Kong and Nigeria.